New England Journal of Medicine· 2013Q1· Clinical trial
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- 2,294citations
- Q1SCImago
- 2013year
Short summary
A fixed-dose oral regimen of apixaban was noninferior to conventional therapy for treating acute venous thromboembolism, significantly reducing bleeding events.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Internal Medicine
Internal MedicineMedicine